OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure

Not yet recruitingOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2030

Study Completion Date

August 31, 2030

Conditions
Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)
Interventions
PROCEDURE

Percutaneous coronary intervention with protocolized implantation of a second generation thin-strut bioresorbable scaffold guided by intracoronary imaging

Percutaneous coronary intervention (PCI) with implantation of the MeRes100 thin-strut BRS with protocolized PSP (predilatation, sizing, postdilatation) method and intracoronary imaging guidance.

Sponsors
All Listed Sponsors
collaborator

Meril Life Sciences Pvt. Ltd.

INDUSTRY

collaborator

Angiocare BV, Netherlands

UNKNOWN

collaborator

Salveo Medical BV, Netherlands

UNKNOWN

lead

Albert Schweitzer Ziekenhuis, Netherlands

OTHER

NCT06919562 - OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure | Biotech Hunter | Biotech Hunter